Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP2 | P08253 | 4/20 | 0.41 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.40 |
| ▸ | ANPEP | P15144 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 2/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | KCNN4 | O15554 | 1/20 | 0.38 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.38 |
| ▸ | BRD4 | O60885 | 2/20 | 0.37 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3548775 | 1.00 | MMP2 (0.41) | MMP2SCN9AANPEPALDH1A1KMT2A | |
| SCHEMBL5200976 | 1.00 | MMP2 (0.41) | MMP2SCN9AANPEPALDH1A1KMT2A | |
| SCHEMBL29276034 | 1.00 | MMP2 (0.41) | MMP2SCN9AANPEPALDH1A1KMT2A | |
| SCHEMBL31696759 | 1.00 | MMP2 (0.41) | MMP2SCN9AANPEPALDH1A1KMT2A | |
| SCHEMBL26062663 | 1.00 | MMP2 (0.41) | MMP2SCN9AANPEPALDH1A1KMT2A | |
| SCHEMBL2298094 | 0.87 | KCNN4 (0.43) | MMP2ANPEPALDH1A1KMT2ACYP3A4 | |
| SCHEMBL992573 | 0.87 | KCNN4 (0.43) | MMP2ANPEPALDH1A1KMT2ACYP3A4 | |
| SCHEMBL992574 | 0.87 | KCNN4 (0.43) | MMP2ANPEPALDH1A1KMT2ACYP3A4 | |
| SCHEMBL14762802 | 0.85 | ALDH1A1 (0.44) | ALDH1A1KMT2AKDM4EMEN1CYP1A2 | |
| SCHEMBL6586331 | 0.85 | MMP2 (0.41) | MMP2ANPEPKMT2ACYP3A4KCNN4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118302417-A | NLRP3 inhibitors | PTC医疗公司 | 2024-07-05 | — | — | CN | disclosed |
| US-7691843-B2 | N-hydroxyamide derivatives possessing antibacterial activity | PFIZER INC. (US) | 2010-04-06 | — | — | US | disclosed |
| US-20080058304-A1 | N-hydroxyamide derivatives possessing antibacterial activity | VICURON HOLDINGS LLC | 2008-03-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080058304-A1 | N-hydroxyamide derivatives possessing antibacterial activity | AMDHD2, OGA, ENGASE | MMP2 1277/4885SCN9A 4080/4885ANPEP 160/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.